Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1278, 2001-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Combination lipid therapy in type 2 diabetes mellitus
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. :
Access to resources
Recommend
Pioglitazone improves lipid profiles in type 2 diabetes
Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. :
Liraglutide reduces HbA1c and bodyweight in type 2 diabetes
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :
Bezafibrate reduces incidence, delays onset of type 2 diabetes
Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. :
Irbesartan reduces progression of renal disease in type 2 diabetes
Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. :